目录
Drugs targeting sympathetic/parasympathetic nerve system
direct sympathomimetics
Selectivity of receptor subtypes
| α1 | α2 | β1 | β2 |
|---|---|---|---|
| adrenaline(epinephrine) | |||
| noradrenaline(norepinephrine) | |||
| isoproterenol | |||
| dobutamine | dobutamine | ||
| phenylephrine | |||
| clonidine | |||
| brimonidine | |||
| naphazoline | |||
| oxymetazoline | |||
| xylometazoline | |||
| fenoterol | |||
| salbutamol | |||
| terbutaline | |||
| salmeterol | |||
| formoterol | |||
direct sympathomimetics
- MAO inhibitor
- MAOA inhibitor：moclobemide
- MAOB inhibitor：selegiline
- amphetamine
- cocaine
sympatholytics
Selectivity of receptor subtypes
| anti α1 | anti α2 | anti β1 | anti β2 |
|---|---|---|---|
| phenoxybenzamine | |||
| phentolamine | |||
| terazosin | |||
| doxazosin | |||
| alfuzosin | |||
| tamsulosin | |||
| propranolol | |||
| metoprolol | |||
| acebutolol | |||
| atenolol | |||
| bisoprolol | |||